We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+7.95%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$7.71B
AUM Growth
+$1.01B
Cap. Flow
+$949M
Cap. Flow %
12.3%
Top 10 Hldgs %
31.27%
Holding
2,619
New
714
Increased
625
Reduced
461
Closed
609

Sector Composition

Rank Sector Weight
1 Technology 9.42%
2 Healthcare 9.32%
3 Consumer Discretionary 7.1%
4 Industrials 6.99%
5 Financials 5.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APG icon
626
APi Group
APG
$17.1B
$1.97M 0.03%
+48,730
New +$2.07M
GAB icon
627
Gabelli Equity Trust
GAB
$1.74B
$1.97M 0.03%
+352,055
New +$2.11M
JBIO
628
Jade Biosciences
JBIO
$1.22B
$1.97M 0.03%
139,968
+58,820
+72% +$852K
MDB icon
629
PUT
MongoDB
MDB
$24B
$1.96M 0.03%
8,000
+2,400
+43% +$803K
XCBE
630
X3 Acquisition Corp
XCBE
$280M
$1.96M 0.03%
+198,900
New +$1.96M
CLF icon
631
Cleveland-Cliffs
CLF
$6.81B
$1.95M 0.03%
230,910
+194,565
+535% +$2.23M
FRO icon
632
Frontline
FRO
$8.75B
$1.94M 0.03%
+55,772
New +$1.7M
TKR icon
633
Timken Company
TKR
$9.82B
$1.94M 0.03%
+19,315
New +$1.92M
LYTS icon
634
LSI Industries
LYTS
$853M
$1.94M 0.03%
104,397
+35,735
+52% +$737K
UHS icon
635
Universal Health Services
UHS
$9.43B
$1.94M 0.03%
10,839
+8,050
+289% +$1.65M
EVLV icon
636
Evolv Technologies
EVLV
$943M
$1.94M 0.03%
319,895
-127,364
-28% -$745K
VLO icon
637
Valero Energy
VLO
$89.8B
$1.93M 0.03%
7,829
+1,816
+30% +$374K
BBT
638
Beacon Financial Corp
BBT
$2.53B
$1.93M 0.03%
+64,450
New +$1.88M
BMRN icon
639
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.93M 0.03%
+34,206
New +$1.99M
ARTC
640
Art Technology Acquisition Corp
ARTC
$1.93M 0.03%
+196,883
New +$1.93M
TPC
641
Tutor Perini Cor
TPC
$4.57B
$1.93M 0.03%
24,948
+15,108
+154% +$1.16M
OKTA icon
642
PUT
Okta
OKTA
$24.1B
$1.92M 0.02%
+24,400
New +$2.02M
GEN icon
643
Gen Digital
GEN
$15.6B
$1.92M 0.02%
101,925
+83,378
+450% +$1.93M
COST icon
644
Costco
COST
$415B
$1.92M 0.02%
1,922
+1,205
+168% +$1.17M
CALX icon
645
Calix
CALX
$2.27B
$1.9M 0.02%
38,866
-25,115
-39% -$1.32M
NEE icon
646
NextEra Energy
NEE
$187B
$1.9M 0.02%
20,430
-1,411
-6% -$125K
SRTA
647
Strata Critical Medical Inc
SRTA
$436M
$1.9M 0.02%
453,882
+104,929
+30% +$505K
HNI icon
648
HNI Corp
HNI
$3B
$1.9M 0.02%
56,783
+21,259
+60% +$942K
APG icon
649
PUT
APi Group
APG
$17.1B
$1.89M 0.02%
+46,700
New +$1.98M
WDAY icon
650
CALL
Workday
WDAY
$33.4B
$1.88M 0.02%
14,500
+4,000
+38% +$635K

Similar funds

Boothbay Fund Management's Q1 2026 Portfolio in Review

As of Q1 2026, Boothbay Fund Management held 2,619 positions worth $7.71B, up 15% from $6.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Boothbay Fund Management deployed $949M of net new capital in Q1 2026, opening 714 new positions and adding to 625 existing holdings. Its largest new stake was Kratos Defense & Security Solutions: 290,936 shares worth $20.5M.

By sector, the portfolio is most concentrated in Technology at 9.4% of assets, down from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $26.3M trimmed.

  • Boothbay Fund Management's largest Q1 2026 buy was Kratos Defense & Security Solutions: 290,936 shares worth $20.5M.
  • Boothbay Fund Management added most to Cornerstone Strategic Value Fund in Q1 2026, an estimated $42.9M increase.
  • Boothbay Fund Management's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $26.3M.
  • Boothbay Fund Management fully exited Cidara Therapeutics in Q1 2026, selling an estimated $17.6M.
  • Boothbay Fund Management's ten largest holdings make up 31% of its $7.71B portfolio in Q1 2026.
  • Boothbay Fund Management opened 714 new positions and closed 609 in Q1 2026.
  • Boothbay Fund Management's portfolio value rose 15% quarter-over-quarter to $7.71B.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.